期刊文献+

促血小板生成素在儿童ITP发病及预后中的作用探讨 被引量:3

Study on the Role of Thrombopoietin in Occurrence and Prognosis of Children ITP
下载PDF
导出
摘要 目的探讨免疫性血小板减少症(ITP)患儿促血小板生成素(TPO)水平与疾病初发状态的相关性;对不同预后组的患儿进行危险因素研究,并分析TPO与其他血小板生发指标的关系,了解TPO在儿童ITP发展中的作用。方法收集2008年9月14日至2012年12月31日期间我院住院治疗ITP患儿的临床资料,检测患儿入院时TPO水平。根据入院时病程分为初发组和非初发组;按疾病转归分为新诊断组、持续性组和慢性组。对初发ITP患儿TPO水平与诊断时血小板计数(PLT)和巨核细胞(MK)计数做相关性分析,了解TPO对疾病发病的作用;分别对不同疾病转归组进行疾病进展危险因素及TPO与MK相关性的分析。结果病例100例,初发组39例,非初发组61例。初发ITP TPO与MK计数的相关性分析r=-0.324,P=0.044,二者呈中度负相关;TPO与PLT无显著相关性(P>0.05)。新诊断组39例,持续性组32例,慢性组29例,各组间TPO水平无统计学差异(P>0.05)。对疾病预后影响因素的分析发现TPO与疾病新诊断状态可能有相关性(P=0.039,但OR值为0.999,95%CI包含1.000);不同预后组中TPO与MK计数的相关性分析仅提示在新诊断和持续性组TPO与MK计数的r=-0.258,P=0.030,二者呈低度负相关。结论 TPO在儿童ITP发生发展中起到了一定作用:初发时TPO水平与MK计数存在负调控关系。12月内获得缓解的病人TPO与MK计数呈低度负相关,提示TPO与MK数量可能共同参与了疾病的进展,其相互关系有待进一步探讨。 Objective To explore effect of thrombopoietin (TPO) on occurrence of children immune thrombocytopenia (ITP). To know TPO' s effect on development of children ITP by looking for risk factors in ITP' s prognosis and analysis relationship between TPO and other indicators related to platelet production in different prognosis groups. Methods We gathered clinical datum of patients admitted in our hospital from Sept. 14th. 2008 to Dec. 31st. 2012,and tested their TPO levels. We divided them into 2 groups depending on course of disease: initial-onset group and non-initial-onset group; we also diveded patients into 3 groups according to their prognosis: newly-diagnosed group, persistent group and chronic group. We did correlation analysis between TPO and PLT/ MK, to figure out TPO' s effect on occurrence of ITP. We analysed risk fac- tors risk in ITP' s prognosis and analysis relationship between TPO and other indicators related to platelet pro- duction in different prognosis groups. Results 100 cases were enrolled, 39 cases were in initial-onset group, 61 cases in the other group. There was negative correlation between TPO and MK( r = -0. 324,P =0.044) , whereas no correlation betweetn TPO and PLT(P 〉 0.05 ). 39 cases were in newly-diagnosed group,32 cases were in persistent group and 29 cases were in chronic group,there was no statistical difference in 3 groups(P 〉 0.05 ). Single- factor logistic regression study showed TPO may be the risk factor in ITP' s prognosis ( P = 0. 039,but OR were 0. 999,95% CI contains 1 ); TPO and MK only had lowly negative correlation (r = -0. 258 ,P = 0. 030 ) in newly-diagnosed and persistant group. Conclusion TPO may had effect on or-rcurence and development in children ITP to some extent: there existed negative modulation between TPO and MK in initial-onset ITP. Patients who had been relieved from thrombocytopenia within 12 months had low neg- ative correlation between TPO and MK, indicating TPO and MK possibiliy took part in development of ITP, while underlying pathogenesis still needed exploration.
出处 《血栓与止血学》 2014年第2期49-52,56,共5页 Chinese Journal of Thrombosis and Hemostasis
关键词 免疫性血小板减少症 儿童 促血小板生成素 Immune thrombocytopenia Children Thrombopoietin
  • 相关文献

参考文献20

  • 1YONG M,SCHOONEN W M,Ll L,KANAS G,et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database[J]. BrJ Haematol,201O,149(6): 855-864.
  • 2D' ORAZIOJ A, NEELYJ, F ARHOUDI N. ITP in children: patho?physiology and current treatment approaches[J].J Pediatr Hematol Oncol,2013,35(1): 1-13.
  • 3MEDEIROS D, BUCHANAN G R. Idiopathic thrombocytopenic pur?pura: beyond consensusj]]. Curr Opin Pediatr,2000,12( I): 4-9.
  • 4BUSSELJB, BUCHANAN GR, NUGENT OJ, et al. A randomized, double- blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia[J]. Blood, 2011 , 118 ( I) : 28-36.
  • 5成人原发免疫性血小板减少症诊治的中国专家共识(修订版)[J].中华血液学杂志,2011,32(3):214-216. 被引量:205
  • 6RODEGHIERO F, STASI R, GERNSHEIMER T, et al. Standardiza?tion of terminology, definitions and outcome criteria in immune throm?bocytopenic purpura of adults and children: report from an interna?tional working group[J]. Biood,2009,1l3(11 ): 2386-2393.
  • 7赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 8王书杰,杨仁池,邹萍,侯明,吴德沛,沈志祥,卢锡京,李艳,陈协群,牛挺,孙慧,于力,王昭,张茵,常乃柏,张高魁,赵永强.重组人血小板生成素治疗特发性血小板减少性紫癜的多中心随机对照临床试验[J].血栓与止血学,2010,16(4):149-153. 被引量:60
  • 9ZHAOJZ,MEI YJ,GUO ZK,et al. Thrombopoietin , a potential T?helper lymphocyte stimulator. Change in T - lymphocyte composition and blood cytokine levels in thrombopoietin cDNA transferred mice[J]. Haematologica, 1998 ,83 (6) : 572-573.
  • 10LlJ, XIA Y, KUTER DJ. Interaction of thrombopoietin with the platelet c- mpl receptor in plasma: binding, internalization, stability and pharmacokinetics[J]. BrJ Haematol,1999,106(2): 345-356.

二级参考文献23

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 2KUTER DJ.Future directions with platelet growth factors[J].Seminar Hemotol,2000,37:41-49.
  • 3CHANG M,NAKAGAWA PA,WILLIAMS SA,et al.Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro[J].Blood,2003,102:887-895.
  • 4WENDLING F,MARASKOVSKY E,DEBILI N,et al.cMpl lig-and is a humoral regulator of megakaryocytopoiesis[J].Nature,1994,369:571-574.
  • 5SABATH DF,KAUSHANSKY K,BROUDY VC.Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding[J].Blood,1999,94:365-367.
  • 6CREMER M,SCHULZE H,LINTHORST G,et al.Serum levels of thrombopoietin,IL-11,and IL-6 in pediatric thrombocytopenias[J].Ann Hematol,1999,78:401-407.
  • 7von dem BORNE A,FOLMAN C,van den OUDENRIJN S,et al.The potential role of thrombopoietin in idiopathic thrombocytopenicpurpura[J].Blood Rev,2002,16,57-59.
  • 8LI J,YANG C,XIA Y,et al.Thrombocytopenia caused by the development of antibodies to thrombopoietin[J].Blood,2001,98:3241-3248.
  • 9BASSER RL,O' FLAHERTY E,GREEN M,et al.Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor[J].Blood,2002,99:2599-2602.
  • 10KUTER DJ.New drugs for familiar therapeutic targets? thrombopoietin receptor agonists and immune thrombocytopenic purpura[J].Eur j Haematol(Suppl),2008,(69):9-18.

共引文献330

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部